Global Lateral Epicondylitis Treatment Market

Market Scope:

The global Lateral Epicondylitis Treatment market is projected to grow significantly, registering a CAGR of 6.3% during the forecast period (2024 – 2032).

Lateral epicondylitis, commonly referred to as tennis elbow, involves the degeneration of tendons attached to the bone, leading to pain. The tendon's primary function is to anchor muscles to the bone, and its weakening can cause considerable discomfort, especially during activities like lifting and gripping. The inflammation of elbow tendons and associated joint pain in lateral epicondylitis can be attributed to various factors, such as repetitive swinging motions of the forearm and elbow. Individuals engaging in activities like tennis, swimming, basketball, and golf, as well as those in certain professions like plumbing and carpentry, are more prone to developing this condition, contributing to the expansion of the lateral epicondylitis treatment market. The repetitive use of the wrist against resistance is a common cause of this condition, and inappropriate weight usage in fitness centers can also be a factor. Additionally, the geriatric population, aged 60 and above, is more susceptible to developing lateral epicondylitis due to tendon weakening. These factors are anticipated to boost the growth of the lateral epicondylitis market. Ongoing trials for potential treatments include drugs like botulinum toxin, topical nitrates, and hyaluronate sodium.
Market Overview:
Driver: The rise in bone injury cases and technological advancement are predicted to foster the market growth.

According to records from the National Institute for Health and Care Excellence (NICE), tennis elbow affected 1%-3% of the U.K. population in 2012. It has been observed that individuals aged 60 and above experience a higher incidence of elbow pain. Consequently, the rapidly growing elderly population and the increasing occurrence of arm fractures due to accidents are expected to propel the elbow lesion treatment market in the near future, contributing to market growth. The continuous introduction of advanced techniques over the decades is further driving market expansion. For example, platelet-rich plasma (PRP) is becoming a preferred method for treating tennis elbow. This procedure involves extracting a blood sample from the patient, which is then processed to increase the concentration of platelets compared to other cells in the sample. Physical therapies like muscle stimulation and ice massage are employed to expedite the healing process. Hence, these innovative techniques play a significant role in boosting the growth of the market.

Opportunities: Growing occurrence of sports injuries aw well as surging R&D activities is expected to pave the way for market growth in the upcoming years.

The growth of the elbow lesion market in the United States is being propelled by the increasing number of sports events and competitions, the presence of excellent medical facilities, and favorable reimbursement policies. Elbow injuries are commonly expected outcomes in throwing sports. According to a study published in the Orthopedic Journal of Sports Medicine in 2013, approximately 30% of baseball players experience elbow pain each year, with around 60% of players displaying radiographic abnormalities when experiencing such pain. In emerging markets like India, China, Russia, and Brazil, the elbow lesion market is expanding due to the rising incidence of sports injuries in these regions, the utilization of advanced diagnostic technologies, and the improvement of medical facilities by both government and private entities. Increasing research and development (R&D) activities are creating additional opportunities for market growth, with major institutes focusing on studying elbow lesions and related conditions. For example, in September 2019, a research study conducted by the Lutheran University of Brazil and published in the Journal of Shoulder and Elbow Surgery found that Iontophoresis proved to be an effective technique in reducing pain and enhancing strength and function in individuals with tennis elbow.
Covid Impact:
Due to the COVID-19 pandemic, the market for tennis elbow treatment faced setbacks as sports events were halted, delayed, or canceled, leading to a decline in sports participation. In addition to impacting business operations, the emergence of the novel Coronavirus has had repercussions on the global economy. The high infection rates and adverse effects on public health systems prompted many countries to implement nationwide lockdowns. Approximately 90% of all clinical trials were either completely halted or indefinitely postponed, negatively impacting the progress of new treatments, medications, and associated services. The emergence of the novel coronavirus has not only affected business operations but has also had a substantial impact on the global economy. High infection rates and the adverse consequences on public health systems prompted numerous countries to implement nationwide lockdowns. This, in turn, had a significant effect on the progress of developing new treatment methods, medications, and related services, with nearly 90% of all clinical trials being either completely halted or indefinitely postponed. To adapt to the situation and create new business opportunities, industry players are exploring digital diagnostic and treatment solutions. The enforced stay-at-home measures resulted in a decline in the number of diagnoses and medical treatments for conditions like tennis elbow. With a heightened emphasis on social distancing, the processes of diagnosis, treatment, and surgeries were put on hold, compelling individuals to manage their conditions at home through complete rest and over-the-counter medications.
Segmentation Analysis:
The surgery segment is anticipated to grow significantly during the forecast period.

Surgery is typically considered the final resort for addressing lateral epicondylitis, encompassing treatments such as arthroscopy, open surgeries, and other surgical interventions. Furthermore, deep tissue massage of the forearm serves as an effective method to alleviate pain and address the injured arm. This approach enhances circulation and incorporates friction therapy on the tendons around the elbow joint, expediting the healing process compared to mere rest. In addition, Transcatheter arterial embolization (TAE) represents a non-surgical, image-guided treatment that aims to reduce irregular blood flow in the affected area, thereby alleviating pain and diminishing inflammation. Lastly, corticosteroid injections, painkillers, and NSAIDs serve as short-term solutions for treatment, although some of these may come with potential side effects.

The hospital segment is anticipated to grow significantly during the forecast period.

The convergence of hospitals and the lateral epicondylitis treatment market underscores the pivotal role that healthcare institutions play in addressing and managing this condition. Hospitals serve as essential centers where individuals seek medical attention for lateral epicondylitis, commonly referred to as tennis elbow. These medical facilities are well-equipped to offer a comprehensive spectrum of treatments, encompassing non-surgical interventions and, in certain cases, surgical alternatives. In the realm of lateral epicondylitis treatment, hospitals frequently adopt a multidisciplinary approach, involving specialists such as orthopedic experts, physical therapists, and other healthcare professionals. Diagnostic procedures, including imaging studies and clinical assessments, are typically carried out within hospital settings to accurately identify and assess the extent of the condition. Furthermore, hospitals significantly contribute to the lateral epicondylitis treatment market by serving as venues for the administration of various treatment modalities. These modalities encompass conservative measures like physical therapy, deep tissue massage, and pharmacological interventions such as corticosteroid injections. In instances where surgical procedures are deemed necessary, hospitals provide the environment for their execution.
Regional Analysis:
The North America region is set to witness significant growth during the forecast period.

In 2022, it was projected that the North American region would dominate the global market for lateral epicondylitis (tennis elbow). The U.S. market for tennis elbow treatment is witnessing growth driven by the rise in sports events, competitions, and increased awareness among patients. Moreover, the escalating risk of sport-related and tennis elbow injuries, particularly in the United States, is driving market expansion. Consequently, there is a heightened demand for various treatment options that alleviate pain and expedite the healing process. Anticipated for 2022, the U.S. region was poised to have a significant share in the North American lateral epicondylitis (tennis elbow) market. Several factors contribute to this market growth, including the increasing incidence of tennis elbow and sports-related injuries, a well-established healthcare infrastructure, high healthcare spending, and growing patient awareness of the condition. Additionally, the expanding senior population in the region, which is more susceptible to elbow problems due to weaker bones, is expected to boost the demand for effective treatment options such as painkillers and physical therapy. These factors are set to propel the market in the region.
Competitive Analysis:
The global Lateral Epicondylitis Treatment market is reasonably competitive with mergers, acquisitions, and product launches. See some of the major key players in the market.

Chen Yueh

• In April 2022, Chen Yueh declared the initiation of a Phase III clinical trial aimed at investigating functional and electromyographical alterations following platelet-rich plasma and dextrose injection for chronic lateral epicondylitis in Taiwan.

Chugai Pharmaceutical

Kasiak Research

Moecular Phramacology Limited

Seikagaku Corporation

Teikoku Pharma

3M

Zimmer Biomet

Veritas Health LLC

Ossur Corporate

OttoBock HealthCare

Johari Digital

AKSIGEN
Scope of the Report
By Treatment Type

• Corticosteroid Injections
• Surgery
• Shock Wave Therapy
• Painkillers and NSAIDS
• Equipment's and Other Products

By Application

• Hospital
• Clinic
• Pharmacy/Drug Stores

By Region

• North America (the United States & Canada)
• Europe (Germany, UK, France, Spain, Italy, and the Rest of Europe)
• Asia Pacific (China, Japan, India, and Rest of Asia Pacific)
• Rest of the World (the Middle East & Africa, and Latin America)

Key reason to purchase this report

It provides a technological development map over time to understand the industry’s growth rate and indicates how the Lateral Epicondylitis Treatment market is evolving.

The report offers a dynamic method to various factors that drive or restrain the growth of the market and specifies which Lateral Epicondylitis Treatment submarket will be the main driver of the overall market from 2024 to 2032.

It renders a definite analysis of changing competitive dynamics and stipulates the leading players and what are their prospects over the forecast period.

It builds a nine-year estimate based on how the market is predicted to grow and shows what will market shares of the global region change by 2032 and which country will lead the market in 2032.